HERS data show lower risk of diabetes

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1376, 2003-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin glargine: commentary on the duration of action and lower risk of nocturnal hypoglycaemia in patients with diabetes

By Rosenstock Julio Owens David

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Sulfonylureas show unfavourable risk profiles

Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Lower risk of pancreatitis with statins

Reactions Weekly, Vol. 1, Iss. 1417, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes: An Overview of Data from PROactive

By Dormandy John

Drug Safety, Vol. 32, Iss. 3, 2009-01 ,pp. : 187-202

Adis International

Access to resources Recommend Favorite

Lipoprotein (a) and Cardiovascular Risk: The Show Must go on

Current Medicinal Chemistry, Vol. 24, Iss. 10, 2017-05 ,pp. : 989-1006

Bentham Science Publishers

Access to resources Recommend Favorite